Skip to content

Ultraverse® RX U420048RXRecalls & reported problems

Bard Peripheral Vascular, Inc. · Ultraverse® RX PTA Dilatation Catheter 4 mm x 80 mm, 200 cm Catheter · Class 2

All models of Ultraverse RX (56)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00801741057533), received between Feb 15, 2018 and Feb 15, 2018 — classified as 1 malfunction.

The most frequently reported specific device problem is “Material Puncture/Hole” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Material Puncture/Hole1
  • Material Rupture1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 15, 2018Material Puncture/Hole; Material Rupture; Material Puncture/Hole; Material Rupture

    IT WAS REPORTED THAT DURING AN ANGIOPLASTY PROCEDURE OF A VEIN GRAFT IN THE LEFT POSTERIOR TIBIAL, THE PTA BALLOON ALLEGEDLY RUPTURED AT 8ATM. THERE WAS NO REPORTED RETRACTION ISSUES. THE PTA BALLOON WAS EXCHANGED OVER THE GUIDEWIRE FOR ANOTHER THAT WAS USED TO COMPLETE THE PROCEDURE. THERE WAS NO REPORTED PATIENT INJURY.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7272964 ↗

Other Catheter, angioplasty, peripheral, transluminal devices

All Catheter, angioplasty, peripheral, transluminal devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page